孤立的乙肝核心抗体与HIV/HCV感染中的晚期肝纤维化相关，但仅在HIV感染中不相关。
Isolated Hepatitis B Core Antibody is Associated With Advanced Hepatic Fibrosis in HIV/HCV Infection But Not in HIV Infection Alone.
作者信息
Bhattacharya Debika, Tseng Chi-Hong, Tate Janet P, Lo Re Vincent, Gibert Cynthia L, Butt Adeel A, Brown Sheldon T, Lim Joseph K, Rodriguez-Barradas Maria C, Rimland David, Kaufman Erica, Justice Amy C, Goetz Matthew Bidwell
机构信息
*VA Greater Los Angeles Healthcare System, Los Angeles, CA †David Geffen School of Medicine, UCLA, Los Angeles, CA ‡VA Connecticut Healthcare System, West Haven, CT §Yale University School of Medicine, New Haven, CT ‖Philadelphia VA Medical Center, Philadelphia, PA ¶Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA #Washington DC VA Medical Center, Washington, DC **George Washington University Medical Center, Washington, DC ††Hamad Healthcare Quality Institute and Hamad Medical Corporation, Doha, Qatar ‡‡VA Pittsburgh Healthcare System, Pittsburgh, PA §§James J. Peters VA Medical Center, Bronx, NY ‖‖Icahn School of Medicine at Mt. Sinai, New York, NY ¶¶Michael E. DeBakey VA Medical Center, Houston, TX ##Baylor College of Medicine, Houston, TX ***Atlanta VA Medical Center, Atlanta, GA †††Emory University School of Medicine, Atlanta, GA ‡‡‡Saint Louis University School of Medicine, Saint Louis, MO.
出版信息
J Acquir Immune Defic Syndr. 2016 May 1;72(1):e14-7. doi: 10.1097/QAI.0000000000000941.
Abstract
HIV+/HCV+ persons with isolated HBcAb have a higher prevalence of advanced fibrosis than persons who are non-immune to HBV, who have resolved HBV, or who are HbsAb+ only.
摘要
与对乙肝病毒无免疫力、已清除乙肝病毒或仅乙肝表面抗体阳性的人相比，孤立性乙肝核心抗体阳性的HIV/HCV合并感染者发生晚期肝纤维化的几率更高。
相似文献
1
Isolated Hepatitis B Core Antibody is Associated With Advanced Hepatic Fibrosis in HIV/HCV Infection But Not in HIV Infection Alone.孤立的乙肝核心抗体与HIV/HCV感染中的晚期肝纤维化相关，但仅在HIV感染中不相关。
J Acquir Immune Defic Syndr. 2016 May 1;72(1):e14-7. doi: 10.1097/QAI.0000000000000941.
2
Isolated Hepatitis B Core Antibody Status Is Not Associated With Accelerated Liver Disease Progression in HIV/Hepatitis C Coinfection.孤立的乙肝核心抗体状态与HIV/丙型肝炎合并感染时肝病进展加速无关。
J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):274-80. doi: 10.1097/QAI.0000000000000969.
3
Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study.丙型肝炎病毒/艾滋病病毒合并感染患者的肝纤维化和免疫表型因丙型肝炎病毒血症而异：一项女性机构间艾滋病研究。
Medicine (Baltimore). 2016 Aug;95(33):e4483. doi: 10.1097/MD.0000000000004483.
4
Liver stiffness values in HIV-infected patients with isolated anti-hepatitis B core antibodies.乙型肝炎核心抗体单独阳性的 HIV 感染患者的肝硬度值。
Med Mal Infect. 2013 Jun;43(6):222-5. doi: 10.1016/j.medmal.2013.02.011. Epub 2013 Apr 15.
5
Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.尼日利亚半干旱地区献血者中分离出的抗-HBc-IgM抗体。
Hum Antibodies. 2011;20(3-4):77-82. doi: 10.3233/HAB-2011-0242.
6
Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.在仅乙肝核心抗体阳性的HIV感染患者中隐匿性乙肝病毒感染
Intervirology. 2008;51(4):270-4. doi: 10.1159/000160217. Epub 2008 Oct 7.
7
8
Low prevalence of ongoing hepatitis B viremia in HIV-positive individuals with isolated antibody to hepatitis B core antigen.在仅乙肝核心抗原抗体阳性的HIV感染者中，乙肝病毒血症持续存在的患病率较低。
J Acquir Immune Defic Syndr. 2003 Dec 1;34(4):439-41. doi: 10.1097/00126334-200312010-00013.
9
Influence of HCV genotype in isolated presence of antibody to hepatitis B core antigen in patients with HIV coinfection.丙型肝炎病毒基因型对合并感染人类免疫缺陷病毒患者单独存在乙型肝炎核心抗体的影响。
J Acquir Immune Defic Syndr. 2006 Aug 15;42(5):647-9. doi: 10.1097/01.qai.0000223020.93944.f7.
10
Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients.在感染HIV的患者中分离出的抗乙型肝炎病毒核心抗原的抗体。
HIV Med. 2004 May;5(3):171-3. doi: 10.1111/j.1468-1293.2004.00206.x.
引用本文的文献
1
Discordant Liver Fibrosis Predictors in Virologically Suppressed People Living with HIV without Hepatitis Virus Infection.病毒学抑制的未感染肝炎病毒的艾滋病毒感染者中不一致的肝纤维化预测因素
Diagnostics (Basel). 2021 Dec 22;12(1):14. doi: 10.3390/diagnostics12010014.
2
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients.来自意大利HIV感染患者ICONA队列的HIV/HCV阳性受试者中，乙肝核心抗体阳性会增加发生严重肝纤维化的风险。
Open Forum Infect Dis. 2020 Nov 18;8(1):ofaa566. doi: 10.1093/ofid/ofaa566. eCollection 2021 Jan.
3
Cryptic HBV Replicative Activity Is Frequently Revealed in Anti-HBc-Positive/HBsAg-Negative Patients with HIV Infection by Highly Sensitive Molecular Assays, and Can Be Predicted by Integrating Classical and Novel Serological HBV Markers.通过高灵敏度分子检测，在抗-HBc阳性/HBsAg阴性的HIV感染患者中经常发现隐匿性HBV复制活性，并且可以通过整合经典和新型血清学HBV标志物来预测。
Microorganisms. 2020 Nov 18;8(11):1819. doi: 10.3390/microorganisms8111819.
4
Chronic Hepatitis B in US Veterans.美国退伍军人中的慢性乙型肝炎
Curr Hepatol Rep. 2019;18(3):310-315. doi: 10.1007/s11901-019-00479-9. Epub 2019 Jul 29.
5
Isolated Anti-HBc: Significance and Management.孤立性抗-HBc：意义与处理
J Clin Med. 2020 Jan 11;9(1):202. doi: 10.3390/jcm9010202.
6
HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy.HBcAb 血清学阳性与意大利一线治疗的 HIV/HBV 合并感染患者的 HIV 病毒血症控制不佳相关。
Sci Rep. 2019 Aug 16;9(1):11942. doi: 10.1038/s41598-019-46976-1.
7
Significance and Management of Isolated Hepatitis B Core Antibody (Anti-HBc) in HIV and HCV: Strategies in the DAA Era.乙型肝炎核心抗体（抗-HBc）单项阳性在 HIV 和 HCV 患者中的意义及处理：DAA 时代的策略。
Curr HIV/AIDS Rep. 2018 Apr;15(2):172-181. doi: 10.1007/s11904-018-0379-y.
8
Update in HIV-hepatitis C virus coinfection in the direct acting antiviral era.直接抗病毒药物时代的HIV-丙型肝炎病毒合并感染的最新情况
Curr Opin Gastroenterol. 2017 May;33(3):120-127. doi: 10.1097/MOG.0000000000000347.
本文引用的文献
1
Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study.抗逆转录病毒治疗的 HIV 和丙型肝炎病毒合并感染患者与丙型肝炎病毒单感染患者的肝失代偿比较：一项队列研究。
Ann Intern Med. 2014 Mar 18;160(6):369-79. doi: 10.7326/M13-1829.
2
Very low prevalence and no clinical significance of occult hepatitis B in a cohort of HIV-infected patients with isolated anti-HBc seropositivity: the BHOI study.在一组单纯抗-HBc血清学阳性的HIV感染患者中，隐匿性乙型肝炎的患病率极低且无临床意义：BHOI研究
HIV Clin Trials. 2008 Sep-Oct;9(5):337-40. doi: 10.1310/hct0905-337.
3
Incidence of transaminitis among HIV-infected patients with occult hepatitis B.隐匿性乙型肝炎的HIV感染患者中谷丙转氨酶升高的发生率。
J Clin Virol. 2008 Sep;43(1):32-6. doi: 10.1016/j.jcv.2008.03.030. Epub 2008 May 16.
4
Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women.HIV 感染女性中隐匿性乙型肝炎病毒感染的患病率及长期影响
Clin Infect Dis. 2007 Sep 15;45(6):736-40. doi: 10.1086/520989. Epub 2007 Aug 10.
5
Hepatitis B virus and HIV coinfection: relationship of different serological patterns to survival and liver disease.乙型肝炎病毒与艾滋病毒合并感染：不同血清学模式与生存及肝脏疾病的关系
HIV Med. 2007 Jul;8(5):271-9. doi: 10.1111/j.1468-1293.2007.00469.x.
6
Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?丙型肝炎病毒（HCV）与人类免疫缺陷病毒（HIV）合并感染情况下的隐匿性乙型肝炎病毒感染：具有临床相关性还是诊断问题？
J Med Virol. 2007 Jun;79(6):694-700. doi: 10.1002/jmv.20836.
7
Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients.HIV感染患者中隐匿性乙型肝炎病毒感染的患病率、危险因素及转归
J Acquir Immune Defic Syndr. 2007 Mar 1;44(3):315-20. doi: 10.1097/QAI.0b013e31802ea499.
8
Development and verification of a "virtual" cohort using the National VA Health Information System.利用国家退伍军人事务部健康信息系统开发并验证一个“虚拟”队列。
Med Care. 2006 Aug;44(8 Suppl 2):S25-30. doi: 10.1097/01.mlr.0000223670.00890.74.
9
Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy.隐匿性乙型肝炎病毒感染对抗逆转录病毒治疗初治的HIV患者的影响。
AIDS. 2006 Jun 12;20(9):1253-60. doi: 10.1097/01.aids.0000232232.41877.2a.
10
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.开发一种简单的非侵入性指标以预测HIV/HCV合并感染患者的显著纤维化。
Hepatology. 2006 Jun;43(6):1317-25. doi: 10.1002/hep.21178.
Zotero 插件